The detection of cognitive impairment among substance-abusing patients: The accuracy of the neuropsychological assessment battery - Screening module

Experimental and Clinical Psychopharmacology

Volumn 12, Issue 3, 2004, Pages 200-207

  Grohman, Kerry ^a,b   Fals Stewart, William ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL ASSESSMENT BATTERY SCREENING MODULE; NEUROPSYCHOLOGICAL TEST; RELIABILITY; RESIDENTIAL CARE; SUBSTANCE ABUSE;

ADULT; COGNITION DISORDERS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 3342964036     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.12.3.200     Document Type: Article

References (51)

1. Allison, W. M., & Jerrom, D. W. A. (1984). Glue sniffing: A pilot study of the cognitive effects of long-term use. International Journal of Addiction, 19, 453-458.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Armitage, S. G. (1946). An analysis of certain psychological tests used for evaluation of brain injury. Psychological Monographs, 60(Whole No. 277).
4. Bates, M. E., Bowden, S. C., & Barry, D. (2003). Neurocognitive impairment associated with alcohol use disorders: Implications for treatment. Experimental and Clinical Psychopharmacology, 10, 193-212.
5. Bates, M. E., & Convit, A. (1999). Neuropsychology and neuroimaging of alcohol and drug abuse. In A. Calev (Ed.), Neuropsychological functions in psychiatric disorders (pp. 342-375). Washington, DC: American Psychiatric Press.
6. Beck, A. T., & Beamesderfer, A. (1974). Assessment of depression: The Beck Depression Inventory. In P. Pichot (Ed.), Psychological measurements in psychopharmacology (pp. 151-169). Basel, Switzerland: Kargel.
7. Benton, A. L., & Hamsher, K. (1976). Multilingual Aphasia Examination. Iowa City, IA: Department of Neurology, University Hospitals.
8. Bergman, H., Borg, S., Engelbrecktson, K., & Vikander, B. (1989). Dependence on sedative hypnotics: Neuropsychological impact, field dependence and clinical consequences in a 5-year follow-up study. British Journal of Addiction, 84, 547-553.
9. Blair, J. R., & Spreen, O. (1989). Predicting premorbid IQ: A revision of the National Adult Reading Test. Clinical Neuropsychologist, 3, 129-136.
10. Blazer, D. G., & Hays, J. C. (1998). An introduction to clinical research in psychiatry. New York: Oxford University Press.
11. Egan, J. P. (1975). Signal detection theory and ROC analysis. New York: Academic Press.
12. Errico, A. L., Nixon, S. J., Parsons, O. A., & Tassey, J. (1990). Screening for neuropsychological impairment in alcoholics. Psychological Assessment, 2, 45-50.
13. Errico, A. L., Parsons, O. A., & King, A. C. (1991). Assessment of verbosequential and visuospatial cognitive abilities in chronic alcoholics. Psychological Assessment, 3, 693-696.
14. Fals-Stewart, W. (1993). Neurocognitive defects and their impact on substance abuse treatment. Addictions and Offender Counseling, 13, 46-57.
15. Fals-Stewart, W. (1996). Intermediate length screening of impairment among psychoactive substance-abusing patients: A comparison of two batteries. Journal of Substance Abuse, 8, 1-17.
16. Fals-Stewart, W. (1997). Detection of neuropsychological impairment among substance-abusing patients: Accuracy of the neurobehavioral cognitive status examination. Experimental and Clinical Psychopharmacology, 5, 269-276.
17. Fals-Stewart, W., & Bates, M. E. (2003). The neuropsychological test performance of drug-abusing patients: An examination of latent cognitive abilities and associated risk factors. Experimental and Clinical Psychopharmacology, 11, 34-45.
18. Fals-Stewart, W., & Lucente, S. (1994). Effect of neurocognitive status and personality functioning on length of stay in residential treatment: An integrative study. Psychology of Addictive Behaviors, 8, 179-190.
19. Fals-Stewart, W., O'Farrell, T. J., Freitas, T. T., McFarlin, S. K., & Rutigliano, P. (2000). The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. Journal of Consulting and Clinical Psychology, 68, 134-144.
20. First, M., Spitzer, L., Gibbon, M., & Williams, J. (1995). Structural Clinical Interview for Axis I DSM-IV Disorders (SCID). Washington, DC: American Psychiatric Association.
21. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
22. Goldman, M. (1990). Experience-dependent neuropsychological recovery and the treatment of chronic alcoholism. Neuropsychology Review, 1, 75-101.
23. Grant, I. (1987). Alcohol and the brain: Neuropsychological correlates. Journal of Consulting and Clinical Psychology, 55, 310-324.
24. Grohman, K., & Fals-Stewart, W. (2003). Computer-assisted cognitive rehabilitation with substance-abusing patients: Effects on treatment response. The Journal of Cognitive Rehabilitation, 21, 10-17.
25. Heaton, R. K., & Crowley, T. J. (1981). Effects of psychiatric disorders and their somatic treatments on neuropsychological test results. In S. B. Filskov & T. J. Bolls (Eds.), Handbook of clinical neuropsychology (pp. 481-525). New York: Wiley.
26. Heaton, R. K., Thompson, L. L., Nelson, L. M., Filley, C. M., & Franklin, G. M. (1990). Brief and intermediate length screening of neuropsychological impairment in multiple sclerosis. In S. M. Rao (Ed.), Multiple sclerosis: A neuropsychological perspective (pp. 149-160). New York: Oxford University Press.
27. Knight, R. G., & Longmore, B. E. (1994). Clinical neuropsychology of alcoholism. Hillsdale, NJ: Erlbaum.
28. Lilliquist, M. W., & Bigler, E. D. (1992). Neurological and neuropsychological consequences of drug abuse. In D. I. Templer, L. C. Hartladge, & W. G. Cannon (Eds.), Preventable brain damage: Brain vulnerability and brain health (pp. 161-192). New York: Springer Publishing Company.
29. McCrady, B. S., & Smith, D. E. (1986). Implications of cognitive impairment for the treatment of alcoholism. Alcoholism: Clinical and Experimental Research, 10, 145-149.
30. Miller, L. (1985). Neuropsychological assessment of substance abusers: Review and recommendations. Journal of Substance Abuse Treatment, 2, 5-17.
31. Nelson, A., Fogel, B. S., & Faust, D. (1986). Bedside cognitive screening instruments: A critical assessment. Journal of Nervous and Mental Disease, 174, 73-83.
32. Northern California Neurobehavioral Group. (1988). Manual for the Neurobehavioral Cognitive Status Examination. Fairfax, CA: Author.
33. O'Malley, S., Adamse, M., Heaton, R. K., & Gawin, F. H. (1992). Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse, 18, 131-144.
34. Osterrieth, P. A. (1944). Le test de copie d'une figure complexe: Contribution a l'etude de la perception et de la memoire. Archives de Psychologie, 30, 206-356.
35. Parsons, O. A., & Farr, S. P. (1981). The neuropsychology of alcohol and drug abuse. In S. B. Filskov & T. J. Boll (Eds.), Handbook of clinical neuropsychology (pp. 320-365). New York: John Wiley.
36. Pfefferbaum, A., Sullivan, E., Rosenbaum, M., Shear, P., Mathalon, D., & Lim, K. (1993). Increase in brain cerebrospinal fluid volume is greater in older than in younger alcoholic patients: A replication study and CT/MRI comparison. Psychiatry Research Neuroimaging, 50, 257-274.
37. Pritchard, W. S., & Robinson, J. H. (1998). Effects of nicotine on human performance. In J. Snel & M. Lorist (Eds.), Nicotine, caffeine, and social drinking: Behaviour and brain function (pp. 21-81). Amsterdam: Harwood Academic.
38. Reitan, R. M., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press.
39. Rennicke, P. M., Keiser, T., Rodin, E., Rim, L., & Lennox, K. (1974, December). Carbamazepine: Behavioral side effects in temporal lobe epilepsy during short-term comparison with placebo. Paper presented at the annual meeting of the American Epilepsy Society, New York.
40. Richards, M., Jarvis, M. J., Thompson, N., & Wadsworth, M. E. J. (2003). Cigarette smoking and cognitive decline in midlife: Evidence from a prospective birth cohort study. American Journal of Public Health, 93, 994-998.
41. Rourke, S. B., & Loberg, T. (1996). The neurobehavioral correlates of alcoholism. In I. Grant & K. M. Adams (Eds.), Neuropsychological assessment of neuropsychiatric disorders (pp. 423-485). New York: Oxford University Press.
42. Sobell, L. C., & Sobell, M. B. (1996). Timeline Followback user's guide: A calendar method for assessing alcohol and drug use. Toronto, Ontario, Canada: Addiction Research Foundation.
43. Smith, A. (1973). Digit-Symbol Modalities Test. Los Angeles: Western Psychological Services.
44. Stebbins, G. T., Wilson, R. S., Gilley, D. W., Bernard, B. A., & Fox, J. H. (1990). Use of the National Adult Reading Test to estimate premorbid IQ in dementia. Clinical Neuropsychologist, 4, 64-68.
45. Stern, R. A., & White, T. (2003). Neuropsychological Assessment Battery: Administration, scoring, and interpretation manual. Lutz, FL: Psychological Assessment Resources.
46. Swets, J. A. (1988, June 3). Measuring the accuracy of diagnostic systems. Science, 240, 1285-1293.
47. Volkow, N. D., Wang, G. J., Hitzemann, R., Fowler, J., Wolf, A., Overall, J., et al. (1994). Recovery of brain glucose metabolism in detoxified alcoholics. American Journal of Psychiatry, 151, 178-183.
48. Wang, G., Volkow, N., Hitzman, R., Oster, Z., Roque, C., & Cestaro, V. (1992). Brain imaging of an alcoholic with MRI, SPECT, and PET. American Journal of Physiologic Imaging, 7, 194-198.
49. Wechsler, D. (1945). A standardized memory scale for clinical use. Journal of Psychology, 19, 87-95.
50. Weinstein, C. S., & Shaffer, H. J. (1993). Neurocognitive aspects of substance abuse treatment: A psychotherapist's primer. Psychotherapy: Theory, Research, Practice, Training, 30, 317-333.
51. Westhuis, D., & Thyer, B. A. (1989). Development and validation of the Clinical Anxiety Scale: A rapid assessment instrument for empirical practice. Education and Psychological Measurement, 49, 153-163.